Tarit Mukhopadhyay

Merck & Co., Inc., Rahway, NJ, USA (United States) — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

13h-index382citations50works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(11), Viral gastroenteritis research and epidemiology(11), Viral Infectious Diseases and Gene Expression in Insects(11), Protein purification and stability(10), SARS-CoV-2 and COVID-19 Research(5)

Publications50 total

Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera
EBioMedicine·2022· 21 citedOpen Access
Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus
Microbial Cell Factories·2021· 19 citedOpen Access
Rapid Developability Assessments to Formulate Recombinant Protein Antigens as Stable, Low-Cost, Multi-Dose Vaccine Candidates: Case-Study With Non-Replicating Rotavirus (NRRV) Vaccine Antigens
Journal of Pharmaceutical Sciences·2020· 20 citedOpen Access
Macroscopic modeling of bioreactors for recombinant protein producing <i>Pichia pastoris</i> in defined medium
Biotechnology and Bioengineering·2020· 19 citedOpen Access
Mechanism of Thimerosal-Induced Structural Destabilization of a Recombinant Rotavirus P[4] Protein Antigen Formulated as a Multi-Dose Vaccine
Journal of Pharmaceutical Sciences·2020· 10 citedOpen Access
Molecular Engineering Improves Antigen Quality and Enables Integrated Manufacturing of A Trivalent Subunit Vaccine Candidate for Rotavirus
Research Square (Research Square)·2020· 5 citedOpen Access
Holistic process development to mitigate proteolysis of a subunit rotavirus vaccine candidate produced in <scp> <i>Pichia pastoris</i> </scp> by means of an acid pH pulse during fed‐batch fermentation
Biotechnology Progress·2020· 18 citedOpen Access
Author response for "Holistic process development to mitigate proteolysis of a subunit rotavirus vaccine candidate produced in &lt;i&gt;Pichia pastoris&lt;/i&gt; by means of an acid pH pulse during fed‐batch fermentation"
2020· 1 cited
Vaccine Technology VII: Beyond the “decade of vaccines”
Vaccine·2019· 1 citedOpen Access
Lentiviral Vector Purification Using Nanofiber Ion-Exchange Chromatography
Molecular Therapy — Methods & Clinical Development·2019· 39 citedOpen Access
Process mapping of vaccines: Understanding the limitations in current response to emerging epidemic threats
Vaccine·2019· 19 citedOpen Access
Automated filtration screening of lentiviral vectors with multiple envelope proteins
2019
Lentivector Producer Cell Lines with Stably Expressed Vesiculovirus Envelopes
Molecular Therapy — Methods & Clinical Development·2018· 16 citedOpen Access
Vaccine Technology VI: Innovative and integrated approaches in vaccine development
Vaccine·2018
Ultra scale‐down approaches to study the centrifugal harvest for viral vaccine production
Biotechnology and Bioengineering·2018· 3 citedOpen Access
Fully automated high-throughput process development for the novel purification of rotavirus vaccines
2018
Superinfection arising in stable lentiviral vector producer cell lines bearing Cocal-G envelope proteins
2018
Affinity resin screening for optimal DSP – application to rotavirus vaccine production.
2018
Virus-like particles: A flexible platform for universal influenza vaccine development
2018
Rapid fermentation optimization for vaccine development
2018
page 1 of 3Next →

Frequent Co-authors

Nigel J. Titchener‐Hooker(9), Ranga Godavarti(8), Stephen Morris(7), Daniel G. Bracewell(6), Aaron Noyes(6), John M. Hickey(6), Sangeeta B. Joshi(6), David B. Volkin(6), Christopher Perry(5), Jon Coffman(5), Kawaljit Kaur(5), Kerry R. Love(5), J. Christopher Love(5), Yasu Takeuchi(4), Nigel Allison(4), Joseph R. Brady(4), Neil C. Dalvie(4), Mary Kate Tracey(4), M. Lourdes Velez‐Suberbie(4), Gary J. Lye(4)